MaximBio is proud to announce it has signed a new agreement with the National Institutes of Health (NIH) through the Rapid Acceleration of Diagnostics (RADx® ) initiative.

​

MaximBio Expands Sales and Marketing Organization and Adds WellTree Molecular Group as a new Distribution Partner

​

​

Maxim Biomedical Inc. Receives EUA for New ClearDetect™ COVID-19 Antigen Home Test

Maxim Biomedical Ramps Up Manufacturing, Completes Validation of 15-Minute SARS-CoV-2 Antigen Test

Siemens and partners remove barriers, scramble to help protect Americans

The  FDA granted a shelf-life extension for the MaximBio ClearDetect™ COVID-19 Antigen Home Test, which extended the shelf-life of all ClearDetect™ tests to 12 months. Please read more to check the most updated expiration date of your kit.

​

​

Canon Virginia, Inc. (CVI) today announces new relationship with Maxim Biomedical to assemble ClearDetect™ COVID-19 Antigen Home Test Kits.

​

Blind Spot: A Braille Patterned Novel Multiplex Lateral Flow Immunoassay Sensor Array for the Detection of Biothreat Agents

Maxim Biomedical Inc. Rapid Antigen COVID-19 Test to Deliver Results in Less Than 15 Minutes While Reducing Risk of Exposure to Healthcare Workers

The FDA granted a two-month shelf-life extension for the ClearDetect™ COVID-19 Antigen Home Test, which extended the shelf-life of all ClearDetect™ tests from 6 months to 8 months. Please read more to check the most updated expiration date of your kit.

​

MaximBio Reveals Agreement with US DoD for ClearDetect™ COVID-19 Antigen Home Test

​

Maryland Company Poised to Produce Millions of Point-of-Care COVID-19 Tests that Deliver Accurate Results in 15 minutes

The National Institutes of Health Award Maxim Biomedical Millions in Manufacturing and Scale Up Support for MaximBio SARS-CoV-2 Rapid Antigen Test

​

​